GCTK GlucoTrack, Inc.

1.150USD+1.77%Mkt Cap: 1.17M $P/E: —

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a …

Key Statistics

Company
Market Cap1.17M USD
Enterprise Value1.63M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-19.39M USD
Revenue/Share—
Last Price1.150 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees15
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.11
EV/Revenue—
P/S—
P/B-0.27
EPS (TTM)-126.48
EPS (Forward)—
52W Range
1.0700% of range136.29
52W High136.29 USD
52W Low1.070 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-685.57%
ROA-247.36%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.24M USD
CapEx (TTM)96.00K USD
FCF Margin—
FCF Yield-887.51%
Net Debt835.00K USD
Net Debt/EBITDA-0.05
Balance Sheet
Debt/Equity1.22
Current Ratio0.46
Quick Ratio0.38
Book Value/Sh-4.17 USD
Cash/Share1.59 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateAug 31, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.02M
Float636.24K
Insiders7.67%
Institutions12.19%
Short Interest
Short Ratio0.6d
Short % Float12.11%
Short % Out.12.10%
Shares Short96.61K
Short (prev mo.)11.06K
Technical
SMA 504.154 (-72.3%)
SMA 20017.41 (-93.4%)
Beta0.73
S&P 52W Chg16.45%
Avg Vol (30d)2.48M
Avg Vol (10d)8.49M
Technical Indicators
RSI (14)28.8
MACD-0.8503
MACD Signal-0.8643
MACD Hist.+0.0140
BB Upper3.388 USD
BB Middle2.059 USD
BB Lower0.7295 USD
BB Width129.14%
ATR (14)0.4469 USD
Vol Ratio (20d)0.03x